ロード中...
Efficacy and Safety of Topical Clascoterone Cream, 1%, for Treatment in Patients With Facial Acne: Two Phase 3 Randomized Clinical Trials
IMPORTANCE: Acne is a common, multifactorial skin condition, and treatments with novel mechanisms have been elusive. OBJECTIVE: To assess the safety and efficacy of clascoterone cream, 1%, a novel topical androgen receptor inhibitor, in 2 phase 3 randomized clinical trials (CB-03-01/25 and CB-03-01/...
保存先:
| 出版年: | JAMA Dermatol |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Medical Association
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7177662/ https://ncbi.nlm.nih.gov/pubmed/32320027 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamadermatol.2020.0465 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|